149 related articles for article (PubMed ID: 23149367)
21. Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases.
Fife D; Zhu V; Voss E; Levy-Clarke G; Ryan P
Drug Saf; 2014 Mar; 37(3):171-82. PubMed ID: 24526267
[TBL] [Abstract][Full Text] [Related]
22. Fluoroquinolones and peripheral neuropathy.
Med Lett Drugs Ther; 2013 Nov; 55(1429):89. PubMed ID: 24220576
[No Abstract] [Full Text] [Related]
23. FDA and the safe and appropriate antibiotic use of fluoroquinolones.
Tillotson GS
Lancet Infect Dis; 2016 Mar; 16(3):e11-2. PubMed ID: 26973315
[No Abstract] [Full Text] [Related]
24. Fluoroquinolone-induced suicidal ideation.
LaSalvia EA; Domek GJ; Gitlin DF
Gen Hosp Psychiatry; 2010; 32(1):108-10. PubMed ID: 20114138
[No Abstract] [Full Text] [Related]
25. Toxic epidermal necrolysis reaction associated with the use of moxifloxacin.
Howard-Thompson A; Cartmell B; Suda KJ
Int J Antimicrob Agents; 2014 Aug; 44(2):178-9. PubMed ID: 25052867
[No Abstract] [Full Text] [Related]
26. Optimal use of fluoroquinolones in the intensive care unit setting.
Rotschafer JC; Ullman MA; Sullivan CJ
Crit Care Clin; 2011 Jan; 27(1):95-106. PubMed ID: 21144988
[TBL] [Abstract][Full Text] [Related]
27. Ocular and systemic manifestations after oral administration of a high dose of enrofloxacin in cats.
Ford MM; Dubielzig RR; Giuliano EA; Moore CP; Narfström KL
Am J Vet Res; 2007 Feb; 68(2):190-202. PubMed ID: 17269886
[TBL] [Abstract][Full Text] [Related]
28. The Use of Systemic and Topical Fluoroquinolones.
Jackson MA; Schutze GE;
Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940800
[TBL] [Abstract][Full Text] [Related]
29. Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea.
Choi SY; Lim HA; Yim HW; Park YH
PLoS One; 2018; 13(4):e0195563. PubMed ID: 29649310
[TBL] [Abstract][Full Text] [Related]
30. Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015.
Baek YH; Park SJ; Jeong S; Oh IS; Jeong HE; Park KH; Shin JY
Clin Drug Investig; 2018 Dec; 38(12):1179-1188. PubMed ID: 30276555
[TBL] [Abstract][Full Text] [Related]
31. Improving Reporting Quality in Ophthalmologic Observational Studies That Use Big Data: The Case of Retinal Detachment Associated With Fluoroquinolone Use.
Etminan M; Maberley DAL
JAMA Ophthalmol; 2018 Jun; 136(6):611-612. PubMed ID: 29710207
[No Abstract] [Full Text] [Related]
32. The use of systemic and topical fluoroquinolones.
Bradley JS; Jackson MA; ;
Pediatrics; 2011 Oct; 128(4):e1034-45. PubMed ID: 21949152
[TBL] [Abstract][Full Text] [Related]
33. Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study.
Sodhi M; Sheldon CA; Carleton B; Etminan M
Neurology; 2017 Aug; 89(8):792-795. PubMed ID: 28754842
[TBL] [Abstract][Full Text] [Related]
34. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect.
Botelho-Nevers E; Rovery C; Richet H; Raoult D
J Antimicrob Chemother; 2011 Aug; 66(8):1821-30. PubMed ID: 21642652
[TBL] [Abstract][Full Text] [Related]
35. New Warning for Fluoroquinolone Antibiotics.
Aschenbrenner DS
Am J Nurs; 2019 Apr; 119(4):20. PubMed ID: 30896484
[No Abstract] [Full Text] [Related]
36. Diplopia and fluoroquinolones.
Fraunfelder FW; Fraunfelder FT
Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
[TBL] [Abstract][Full Text] [Related]
37. The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.
Novell MJ; Morreale CA
Ann Pharmacother; 2010 May; 44(5):826-31. PubMed ID: 20354161
[TBL] [Abstract][Full Text] [Related]
38. [Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (12):13-6. PubMed ID: 15719658
[No Abstract] [Full Text] [Related]
39. Comparison table: some systemic fluoroquinolones.
Med Lett Drugs Ther; 2018 Mar; 60(1543):e57-e58. PubMed ID: 29635268
[No Abstract] [Full Text] [Related]
40. Clinical inquiries. Is there much risk in using fluoroquinolones in children?
Hernandez R; Edgerton L; Flake D; Groetsch SM
J Fam Pract; 2008 Aug; 57(8):539-40. PubMed ID: 18687231
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
